269 related articles for article (PubMed ID: 10598935)
21. Synthetic fibronectin peptide exerts neuroprotective effects on transient focal brain ischemia in rats.
Zhao LR; Spellman S; Kim J; Duan WM; McCarthy JB; Low WC
Brain Res; 2005 Aug; 1054(1):1-8. PubMed ID: 16054115
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: neuroprotective effects when used alone or in combination with urokinase.
Shuaib A; Yang Y; Li Q
Exp Neurol; 2000 Feb; 161(2):733-9. PubMed ID: 10686092
[TBL] [Abstract][Full Text] [Related]
23. Hyperbaric oxygenation mitigates focal cerebral injury and reduces striatal dopamine release in a rat model of transient middle cerebral artery occlusion.
Yang ZJ; Camporesi C; Yang X; Wang J; Bosco G; Lok J; Gorji R; Schelper RL; Camporesi EM
Eur J Appl Physiol; 2002 Jun; 87(2):101-7. PubMed ID: 12070618
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
25. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.
Sayeed I; Guo Q; Hoffman SW; Stein DG
Ann Emerg Med; 2006 Apr; 47(4):381-9. PubMed ID: 16546625
[TBL] [Abstract][Full Text] [Related]
26. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
[TBL] [Abstract][Full Text] [Related]
27. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat.
Ding G; Jiang Q; Zhang L; Zhang Z; Knight RA; Soltanian-Zadeh H; Lu M; Ewing JR; Li Q; Whitton PA; Chopp M
J Neurol Sci; 2004 Aug; 223(2):135-43. PubMed ID: 15337614
[TBL] [Abstract][Full Text] [Related]
28. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats.
Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R
Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594
[TBL] [Abstract][Full Text] [Related]
29. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic time window of flurbiprofen axetil's neuroprotective effect in a rat model of transient focal cerebral ischemia.
Wang C; Liu JL; Sang HF; Lu Y; Dong HL; Xiong LZ
Chin Med J (Engl); 2008 Dec; 121(24):2572-7. PubMed ID: 19187598
[TBL] [Abstract][Full Text] [Related]
31. THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models.
Krakovsky M; Polianski V; Nimrod A; Higazi A; Leker RR; Lamensdorf I
Neurol Res; 2011 Nov; 33(9):983-90. PubMed ID: 22081002
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
33. A mouse model of embolic focal cerebral ischemia.
Zhang Z; Chopp M; Zhang RL; Goussev A
J Cereb Blood Flow Metab; 1997 Oct; 17(10):1081-8. PubMed ID: 9346433
[TBL] [Abstract][Full Text] [Related]
34. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
35. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Sumii T; Lo EH
Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
[TBL] [Abstract][Full Text] [Related]
36. Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain.
Akamatsu Y; Saito A; Fujimura M; Shimizu H; Mekawy M; Hasumi K; Tominaga T
Neurosci Lett; 2011 Oct; 503(2):110-4. PubMed ID: 21871536
[TBL] [Abstract][Full Text] [Related]
37. Partial intra-aortic occlusion improves perfusion deficits and infarct size following focal cerebral ischemia.
Noor R; Wang CX; Todd K; Elliott C; Wahr J; Shuaib A
J Neuroimaging; 2010 Jul; 20(3):272-6. PubMed ID: 19888934
[TBL] [Abstract][Full Text] [Related]
38. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
39. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Jin R; Xiao AY; Liu S; Wang M; Li G
Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
[TBL] [Abstract][Full Text] [Related]
40. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
